2021-01-05,"Xenetic Biosciences, Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference"
2020-12-14,"Xenetic Biosciences, Inc. Announces Closing of $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules"
2020-12-10,"The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations"
2020-12-10,"Xenetic Biosciences, Inc. Announces $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules"
2020-12-09,Xenetic Biosciences stock more than quadruples on massive volume after partner's upbeat trial news
2020-12-09,"Xenetic Biosciences, Inc. Announces Positive Data from Partners Pivotal Phase 3 Clinical Trial Utilizing PolyXen(R) Platform Technology"
2020-11-13,"Xenetic Biosciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update"
2020-11-05,"Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 6th Annual Israel Conference"
2020-09-09,"Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference"
2020-09-08,Overview Of Value Stocks In The Healthcare Sector
2020-08-13,"Xenetic Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Corporate Update"
2020-07-30,"Xenetic Biosciences, Inc. Strengthens Scientific Advisory Board with Two Key Appointments"
2020-07-01,"Xenetic Biosciences, Inc. Provides Development Update for Its Personalized CAR T Platform Technology, XCART(TM)"
2020-06-16,"Xenetic Biosciences, Inc. Announces Collaboration with Pharmsynthez and Multiple Academic Institutions in Russia and Belarus to Advance Development of XCART(TM) Platform"
2020-06-08,"Xenetic Biosciences, Inc. to Present at the Virtual Investor Fireside Chat Series"
2020-05-19,"Xenetic Biosciences, Inc. Announces Research and Development Collaboration with Scripps Research to Advance XCART(TM) Platform"
2020-05-14,"Xenetic Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update"
2020-04-15,"Xenetic Biosciences, Inc. to Present at the April 2020 Virtual Investor Summit"
2020-03-27,"Xenetic Biosciences, Inc. Reports 2019 Year End Results and Provides Corporate Update"
2020-02-27,Xenetic Biosciences' Webcast Replay from Noble Capital Markets' 16th Annual Investor Conference Presentation Now Available
2020-02-26,"Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board"
2020-02-13,"Xenetic Biosciences, Inc. Strengthens Expertise to Advance XCART Development Program with Appointment of Cell Therapy Expert, Maksim Mamonkin, Ph.D. to Scientific Advisory Board"
2020-02-11,"Xenetic Biosciences, Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference"
2020-01-14,"Xenetic Biosciences, Inc. Announces Publication of Data from Partner's Phase 1/2 Study Evaluating Program Leveraging Polyxen(R) Platform Technology"
2019-11-15,"Xenetic Biosciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Corporate Update"
2019-10-29,"Xenetic Biosciences, Inc. to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference"
2019-10-18,Can Xenetic Biosciences (NASDAQ:XBIO) Fund Its Growth Plans?
2019-10-16,"Xenetic Biosciences, Inc. to Present at BIO Investor Forum"
2019-10-08,"Xenetic Biosciences, Inc. Provides Business Outlook"
2019-07-22,"Xenetic Biosciences, Inc. Closes $15.0 Million Underwritten Public Offering and Completes Acquisition of Innovative CAR T Technology Platform"
2019-07-17,"Xenetic Biosciences, Inc. (Nasdaq: XBIO) Announces Pricing of $15.0 Million Underwritten Public Offering"
2019-07-05,"Xenetic Biosciences Shares Surge After Biotech Prices Common Stock, Warrant Offering"
2019-06-24,"Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock"
2019-06-20,"Introducing Xenetic Biosciences (NASDAQ:XBIO), The Stock That Collapsed 98%"
2019-05-14,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings"
2019-05-13,"Xenetic Biosciences, Inc. Reports First Quarter 2019 Financial Results and Provides Corporate Update"
2019-05-02,"Xenetic Biosciences, Inc. Strengthens Scientific Advisory Board with Appointment of Guenther Koehne, M.D., Ph.D."
2019-04-01,"Xenetic Biosciences, Inc. Reports 2018 Year End Results and Provides Corporate Update"
2019-03-05,Xenetic Biosciences Announces Pricing of $3.1 Million Registered Direct Offering
2019-03-04,"Xenetic Biosciences, Inc. (NASDAQ: XBIO) Announces Agreement to Acquire Innovative CAR T Technology Platform"
2018-12-04,What Investors Should Know About Xenetic Biosciences Incs (NASDAQ:XBIO) Financial Strength
2018-08-14,Why Xenetic Biosciences Just Surged 28 Percent
2018-08-14,"Xenetic Biosciences Oncology Phase II Trial in Process, Pipeline Overview"
2018-08-14,Todays Research Reports on Stocks to Watch: Xenetic Biosciences and Antares Pharma
2018-06-25,Upcoming FDA Catalyst and Disruptive Drug Candidate Indicate Big Near-Term Upside For This Unknown Healthcare Stock
2018-05-25,Interested In Xenetic Biosciences Inc (NASDAQ:XBIO)? Heres How It Performed Recently
2018-02-05,How Does Xenetic Biosciences Inc (NASDAQ:XBIO) Affect Your Portfolio Returns?
2018-01-19,Xenetic Biosciences Inc (NASDAQ:XBIO): Is Now The Time To Bet On Healthcare?
2018-01-02,Does Xenetic Biosciences Incs (NASDAQ:XBIO) CEO Pay Compared Well With Peers?
2017-12-08,Who Really Owns Xenetic Biosciences Inc (XBIO)?
2017-11-30,Does Xenetic Biosciences Incs (XBIO) 83.8% Earnings Growth Make It An Outperformer?
2017-11-15,Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update
2017-11-02,"Xenetic Biosciences Enters Into Sublicense Agreement Related to its PolyXen Technology with Baxalta Inc., a Wholly-owned Subsidiary of Shire plc"
2017-10-31,Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer
2017-10-04,How Should You Think About Xenetic Biosciences Incs (XBIO) Risks?
2017-10-02,Xenetic Biosciences Provides Update on Annual Meeting of Stockholders
2017-08-23,Xenetic Biosciences Announces Dismissal of Annual Meeting of Stockholders
2017-08-15,Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update
2017-08-14,Xenetic Biosciences Announces Appointment of Three Directors to the Board
2017-07-18,"Xenetic Biosciences Announces Adjournment of Annual Meeting of Stockholders until Wednesday, August 16, 2017"
2017-06-26,Xenetic Biosciences Commences Patient Enrollment in Phase 2 Study Evaluating XBIO-101 in Conjunction with Progestin Therapy for the Treatment of Endometrial Cancer
2017-05-22,Shire and tiny Lexington biotech say hemophilia drug trial misses mark
2017-05-22,Xenetic Biosciences Receives Program Update from Partner Shires Phase 1/2 Study Evaluating SHP656 in Development as a Long-acting Treatment for Hemophilia A
2017-05-16,Xenetic Biosciences Reports 2017 First Quarter Financial Results and Provides Business Update
2017-05-09,Xenetic Biosciences to Host 2017 First Quarter Update Conference Call
2017-05-01,Xenetic Biosciences Presents Case Study of PolyXen Platform Technology at the 13th Annual Protein Engineering Summit (PEGS) Boston
2017-04-20,Xenetic Biosciences PolyXen Platform Technology Accepted for Poster Presentation at the 13th Annual Protein Engineering Summit (PEGS) Boston
2017-04-04,Edited Transcript of XBIO earnings conference call or presentation 4-Apr-17 12:30pm GMT
2017-04-04,Edited Transcript of XBIO earnings conference call or presentation 4-Apr-17 12:30pm GMT
2017-04-04,"Xenetic Biosciences Expands Executive Management Team with Appointment of James F. Parslow, MBA, CPA as Chief Financial Officer"
2017-04-04,"Xenetic Biosciences Expands Executive Management Team with Appointment of James F. Parslow, MBA, CPA as Chief Financial Officer"
2017-04-03,Xenetic Biosciences Reports 2016 Year End Financial Results and Provides Business Update
2017-03-31,"XENETIC BIOSCIENCES, INC. Files SEC form 10-K, Annual Report"
2017-03-31,Prana Biotechnology and Xenetic Biosciences Expand Their Product Promotion
2017-03-29,"Xenetic Biosciences, Inc. (Nasdaq: XBIO) to Ring The Nasdaq Stock Market Opening Bell"
2017-03-29,"Xenetic Biosciences to Ring Nasdaq Stock Market Opening Bell on March 30, 2017"
2017-03-27,Xenetic Biosciences Provides Update on Patent Portfolio Development
2017-03-09,Xenetic Biosciences to Present at the 29th Annual ROTH Conference
2017-02-27,"XENETIC BIOSCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year"
2017-01-06,Xenetic Biosciences Receives $3 Million Milestone Payment from Shire plc for PSA-Recombinant SHP656 in Development for Long-Acting Treatment for Hemophilia
2017-01-04,"XENETIC BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Ot"
2017-01-04,"Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer"
2017-01-03,Xenetic Biosciences to Present at Biotech Showcase 2017
2016-12-20,Coverage initiated on Xenetic by Ladenburg Thalmann
2016-12-15,Shire PLC (ADR) (SHPG) Looks To Xenetic Biosciences Inc (XBIO) To Cement Hemophilia Market Share
2016-12-06,"XENETIC BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Ot"
2016-12-05,Xenetic Biosciences Expands Management Team with Key Appointment of Jeffrey F. Eisenberg as Chief Operating Officer
2016-12-01,Xenetic Biosciences to Present at the LD Micro 2016 Annual Conference
2016-11-23,"XENETIC BIOSCIENCES, INC. Financials"
2016-11-23,Xenetic Biosciences to Host Quarterly Update Conference Call and Webcast
2016-11-22,"XENETIC BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Ot"
